Literature DB >> 16335794

Type 2 diabetes in non-obese Indian subjects is associated with reduced leptin levels: study from Mumbai, Western India.

A Rosalind Marita1, Joy A Sarkar, Sujata Rane.   

Abstract

OBJECTIVE: Asian Indian subjects have a high tendency to develop Type 2 diabetes even though obesity is relatively uncommon. We evaluated the serum leptin levels in a group of non-obese Type 2 diabetic patients from Mumbai, Western India.
DESIGN: Cross sectional study.
METHODS: A total of 104 subjects consisting of 28 with Type 2 diabetes, 16 with impaired glucose tolerance and 60 age and sex-matched control subjects were given 75 g oral glucose tolerance test. Fasting serum leptin (IRMA), insulin and C-peptide were measured along with fasting and 2 h plasma glucose. The relation between these variables was studied by univariate and multiple regression analysis.
RESULTS: Type 2 diabetes was associated with marked (50-60%) reduction in serum leptin levels, in both men and women. Women, but not men, with impaired glucose tolerance exhibited 60% lower leptin. Serum leptin levels were positively correlated to body mass index (BMI; r = 0.501, p = 0.001) and calculated body fat percent (r = 0.525, p = 0.001) in all the study subjects with a better correlation in the normal subjects (r = 0.562 for BMI and 0.735 for body fat). On the other hand, serum leptin showed significant correlation to serum insulin (r = 0.362, p = 0.008) only in subjects with diabetes or IGT. In the multiple regression model, BMI was the only independent predictor of leptin, in all the subjects. However, in subjects with diabetes or impaired glucose tolerance, waist circumference (p = 0.003), gender (p = 0.007) and body fat (p = 0.009) were significant predictors of leptin, besides BMI. Gender-specific multiple regression revealed serum insulin as an independent predictor of leptin in men (p = 0.026). Therefore, lower serum leptin levels in diabetes is partly due to increased waist circumference, decreased BMI and male sex. These observations are consistent with the view that leptin levels in this cohort of non-obese Indians from Mumbai exhibit gender-specific relationship partly attributed to changes in serum insulin and waist circumference in men and to changes in BMI, in women.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16335794     DOI: 10.1007/s11010-005-1204-7

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  25 in total

1.  Serum leptin concentrations in young insulin-sensitive and insulin-resistant volunteers.

Authors:  M González-Ortiz; E Martínez-Abundis; B R Balcázar-Muñoz
Journal:  Horm Metab Res       Date:  2000-07       Impact factor: 2.936

Review 2.  Leptin: the tale of an obesity gene.

Authors:  J F Caro; M K Sinha; J W Kolaczynski; P L Zhang; R V Considine
Journal:  Diabetes       Date:  1996-11       Impact factor: 9.461

3.  High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey.

Authors:  A Ramachandran; C Snehalatha; A Kapur; V Vijay; V Mohan; A K Das; P V Rao; C S Yajnik; K M Prasanna Kumar; J D Nair
Journal:  Diabetologia       Date:  2001-09       Impact factor: 10.122

4.  Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development.

Authors:  C Weyer; P A Tataranni; C Bogardus; R E Pratley
Journal:  Diabetes Care       Date:  2001-01       Impact factor: 19.112

5.  Difference in body fat percentage does not explain the gender dimorphism in leptin in Asian Indians.

Authors:  C Snehalatha; A Ramachandran; K Satyavani; S Sivasankari; V Vijay
Journal:  J Assoc Physicians India       Date:  1999-12

6.  Improved glycemic control increases fasting plasma acylation-stimulating protein and decreases leptin concentrations in type II diabetic subjects.

Authors:  M Ozata; D Gungor; M Turan; G Ozisik; N Bingol; T Ozgurtas; I C Ozdemir
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

7.  Glibenclamide, but not acarbose, increases leptin concentrations parallel to changes in insulin in subjects with NIDDM.

Authors:  S M Haffner; M Hanefeld; S Fischer; K Fuçker; W Leonhardt
Journal:  Diabetes Care       Date:  1997-09       Impact factor: 19.112

8.  Leptin levels in type 2 diabetes: associations with measures of insulin resistance and insulin secretion.

Authors:  M Wauters; R V Considine; J S Yudkin; F Peiffer; I De Leeuw; L F Van Gaal
Journal:  Horm Metab Res       Date:  2003-02       Impact factor: 2.936

9.  Marked and rapid decreases of circulating leptin in streptozotocin diabetic rats: reversal by insulin.

Authors:  P J Havel; J Y Uriu-Hare; T Liu; K L Stanhope; J S Stern; C L Keen; B Ahrén
Journal:  Am J Physiol       Date:  1998-05

10.  Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men.

Authors:  M A Banerji; N Faridi; R Atluri; R L Chaiken; H E Lebovitz
Journal:  J Clin Endocrinol Metab       Date:  1999-01       Impact factor: 5.958

View more
  10 in total

1.  Metformin restores the correlation between serum-oxidized LDL and leptin levels in type 2 diabetic patients.

Authors:  Manouchehr Nakhjavani; Afsaneh Morteza; Firuzeh Asgarani; Abnoos Mokhtari; Alireza Esteghamati; Omid Khalilzadeh; Ghazaleh Rahbari
Journal:  Redox Rep       Date:  2011       Impact factor: 4.412

Review 2.  Adiponectin and leptin: potential tools in the differential diagnosis of pediatric diabetes?

Authors:  Milagros Gloria Huerta
Journal:  Rev Endocr Metab Disord       Date:  2006-09       Impact factor: 6.514

3.  Genetic influences on type 2 diabetes and metabolic syndrome related quantitative traits in Mauritius.

Authors:  Jeremy B Jowett; Vincent P Diego; Navaratnam Kotea; Sudhir Kowlessur; Pierrot Chitson; Thomas D Dyer; Paul Zimmet; John Blangero
Journal:  Twin Res Hum Genet       Date:  2009-02       Impact factor: 1.587

4.  Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients.

Authors:  Dominique Hansen; Paul Dendale; Milou Beelen; Richard A M Jonkers; Annelies Mullens; Luk Corluy; Romain Meeusen; Luc J C van Loon
Journal:  Eur J Appl Physiol       Date:  2010-02-04       Impact factor: 3.078

Review 5.  Dysregulated lipid storage and its relationship with insulin resistance and cardiovascular risk factors in non-obese Asian patients with type 2 diabetes.

Authors:  Chatchalit Rattarasarn
Journal:  Adipocyte       Date:  2018-02-07       Impact factor: 4.534

6.  Serum leptin level is reduced in non-obese subjects with type 2 diabetes.

Authors:  Ghorban Mohammadzadeh; Nosratollah Zarghami
Journal:  Int J Endocrinol Metab       Date:  2012-12-21

7.  Effects of improving glycemic control with insulin on leptin, adiponectin, ghrelin and neuropeptidey levels in patients with type 2 diabetes mellitus: a pilot study.

Authors:  Niki Katsiki; Dimitri P Mikhailidis; Anna Gotzamani-Psarrakou; Triantafillos P Didangelos; John G Yovos; Dimitrios T Karamitsos
Journal:  Open Cardiovasc Med J       Date:  2011-06-20

8.  Leptin and adiponectin in relation to body fat percentage, waist to hip ratio and the apoB/apoA1 ratio in Asian Indian and Caucasian men and women.

Authors:  Jessica Smith; Maha Al-Amri; Allan Sniderman; Katherine Cianflone
Journal:  Nutr Metab (Lond)       Date:  2006-04-10       Impact factor: 4.169

9.  Adipokines, oxidized low-density lipoprotein, and C-reactive protein levels in lean, overweight, and obese portuguese patients with type 2 diabetes.

Authors:  Maria João Neuparth; Jorge Brandão Proença; Alice Santos-Silva; Susana Coimbra
Journal:  ISRN Obes       Date:  2013-01-17

10.  Relationship between obesity, adipocytokines and inflammatory markers in type 2 diabetes: relevance for cardiovascular risk prevention.

Authors:  Natasa Rajkovic; Miroslava Zamaklar; Katarina Lalic; Aleksandra Jotic; Ljiljana Lukic; Tanja Milicic; Sandra Singh; Ljubica Stosic; Nebojsa M Lalic
Journal:  Int J Environ Res Public Health       Date:  2014-04-14       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.